share

Anavex 2-73 CAS NO 195615-84-0


Unit Price:

CAS No.:195615-84-0

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Anavex 2-73 is a high-purity, small molecule compound with the CAS registry number 195615-84-0. This compound is of significant interest as a selective σ-1 receptor agonist and muscarinic receptor modulator, primarily investigated for its neuroprotective and neurorestorative properties. It is a critical active pharmaceutical ingredient (API) and research chemical for organizations in the pharmaceutical, biotechnology, and life sciences sectors developing novel therapeutics for central nervous system disorders.

Application

  • Pharmaceutical Active Ingredient (API): Serves as the core active component in the formulation of investigational drugs targeting neurological conditions.
  • Preclinical & Clinical Research: Used as a reference standard and experimental compound in in vitro and in vivo studies to elucidate mechanisms of action and therapeutic efficacy.
  • Neurodegenerative Disease Research: A key material for R&D focused on Alzheimer's disease, Parkinson's disease, and other forms of dementia.
  • Neuroprotection Studies: Employed in research models to investigate compounds that prevent neuronal cell death and support cognitive function.
  • Reference Standard for Analytical Testing: Used in quality control laboratories for method development, validation, and assay calibration via HPLC, LC-MS, or NMR.
  • Process Chemistry & Scale-Up: Supplied for route development, optimization, and the production of batches under current Good Manufacturing Practice (cGMP) guidelines.

Basic Information

Product Name Anavex 2-73
CAS No. 195615-84-0
Molecular Formula C₂₄H₂₉FN₂O₃
Molecular Weight 412.50 g/mol
Synonyms Blarcamesine; ANAVEX2-73; Tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine Hydrochloride; 1-(2,2-Diphenyltetrahydrofuran-3-yl)-N,N-dimethylmethanamine; ANAVEX 2-73; ANAVEX2-73 free base; Anavex2-73; Anavex 273
EINECS Contact for details

Quality Control

Every batch of Anavex 2-73 is manufactured and tested to meet stringent quality standards suitable for pharmaceutical research and development. Our quality assurance protocol includes identity confirmation, purity analysis, and impurity profiling. A comprehensive Certificate of Analysis (COA) is provided with each shipment, detailing specifications and test results from validated analytical methods. We support development with materials produced under quality management systems aligned with cGMP principles for APIs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a dry environment. For long-term storage, consider desiccants or inert atmosphere to maintain stability.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥98.0%
Related Substances (HPLC) Total impurities ≤2.0% Any single unknown impurity ≤0.5%
Water Content (KF) ≤1.0%
Residue on Ignition ≤0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.